Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis: Multicenter, Prospective, Placebo-controlled, Randomized Trial

NCT05841758 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT05841758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05841758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis: Multicenter, Prospective, Placebo-controlled, Randomized Trial
Lead sponsor
Hospices Civils de Lyon
Phase
Phase 4
Overall status
Recruiting
Start date
July 30, 2024
Completion date
July 1, 2029
Enrollment
140 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoidosis, pulmonary